SynthesisArchives of virology2025

Evaluation of recent pre-booster studies on hepatitis B vaccine effectiveness across WHO regions with HBV prevalence above 1% in the general population up to 60 years of age: a systematic review.

Tahereh Zadeh Mehrizi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.